A Spanish missionary priest being treated for Ebola died on August 12 in a Madrid hospital, becoming the first European victim of the deadly disease, amid a worldwide debate over who should get experimental Ebola treatments.
After holding a teleconference with medical experts around the world, the World Health Organization declared it is ethical to use unproven Ebola drugs and vaccines in the current outbreak in West Africa provided the right conditions are met. Its statement, however, sidestepped the key question of how to decide who should get the limited drugs.
Two American aid workers and the Spanish priest who died had gotten a new Ebola drug named ZMapp, which has never been tested in humans.
Two more ZMapp treatments were reportedly heading Tuesday to Liberia to be used on two infected doctors — the first Africans to receive the experimental drug.
The U.N. health agency said 1,013 people have died so far in the Ebola outbreak in West Africa of the 1,848 suspected or confirmed cases recorded by authorities.
The Spanish missionary, 75-year-old Miguel Parajes, died in Madrid’s Carlos III Hospital, the hospital said. His body was scheduled to be cremated yesterday to avoid any further public health risks, the hospital said.
Parajes had worked for the San Juan de Dios hospital order, a Catholic aid group, helping to treat people with Ebola in Liberia when he became ill and was evacuated.
A medical worker collects a biological sample from a girl
at Futian Checkpoint in Shenzhen on August 13 as the city has strengthened preventive measures
in immigration monitoring to prevent Ebola infection.